NCT02003859

Brief Summary

Studies over the past two decades have convincingly demonstrated the role of barrier dysfunction in the pathogenesis of inflammatory bowel disease. It previously shown that optical biopsy with probe-based confocal laser endomicroscopy (pCLE) could be used to assess mucosal barrier function. Furthermore, mucosal barrier dysfunction on pCLE was shown to be predictive of disease relapse in adult IBD patients. The purpose of the current study is to determine the predictive value of pCLE findings in pediatric IBD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

November 30, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 6, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

November 19, 2014

Status Verified

November 1, 2014

Enrollment Period

4 years

First QC Date

November 30, 2013

Last Update Submit

November 18, 2014

Conditions

Keywords

IBDPediatricspCLE

Outcome Measures

Primary Outcomes (1)

  • Primary study end-point was moderate to severe flare requiring hospitalization after pCLE

    The purpose of the current study is to determine the predictive value of pCLE findings in pediatric IBD patients.

    follow up period was a median of 18 months (range 4 to 33)

Eligibility Criteria

Age10 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Pediatric patients with IBD from all over Russia, treated from IBD in our Center

You may qualify if:

  • signed informed consent
  • patients with established IBD

You may not qualify if:

  • Any kind of allergy
  • Bronchial asthma
  • Liver or kidney disease
  • Inability to sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Scientific Center of Children's Health

Moscow, 119991, Russia

Location

Related Publications (1)

  • Shavrov A, Kharitonova AY, Davis EM, Claggett B, Morozov DA, Brown DK, Shavrov AA, Liu JJ. A Pilot Study of Confocal Laser Endomicroscopy to Predict Barrier Dysfunction and Relapse in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):873-8. doi: 10.1097/MPG.0000000000001022.

Biospecimen

Retention: NONE RETAINED

Optical biopsy

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Officials

  • Andrey A Shavrov, M.D.

    The Scientififc Center of Children's Health

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

November 30, 2013

First Posted

December 6, 2013

Study Start

November 1, 2010

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

November 19, 2014

Record last verified: 2014-11

Locations